Vaginal epithelial surface appearances in women using vaginal rings for contraception

被引:25
作者
Fraser, IS [1 ]
Lacarra, M
Mishell, DR
Alvarez, F
Brache, V
Lähteenmäki, P
Elomaa, K
Weisberg, E
Nash, HA
机构
[1] Univ Sydney, Dept Obstet & Gynecol, Sydney, NSW 2006, Australia
[2] Womens & Childrens Hosp, Los Angeles, CA USA
[3] Univ So Calif, Los Angeles, CA USA
[4] Profamilia, Santo Domingo, Dominican Rep
[5] Vaestoliitto, Helsinki, Finland
[6] Family Planning, Sydney Ctr Reprod Hlth Res, Sydney, NSW, Australia
[7] Populat COuncil, Ctr Biomed Res, New York, NY USA
关键词
vaginal rings; colposcopy; vaginal lesions; Nestorone (R); norethindrone acetate; ethinyl estradiol;
D O I
10.1016/S0010-7824(00)00081-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Vaginal inspections using colposcopy before insertion of contraceptive vaginal rings and at e-month intervals during ring use were conducted on 169 users of four different formulations. The rings studied released Nestorone(R) alone (50, 75, 100 mu g daily over 6 months); ethinyl estradiol: Nestorone (30:200 and 25:150 mu g daily over 6 months); ethinylestradiol:norethindrone acetate (20:1000 and 25: 1000 mu g daily over 4 months); and ethinyl estradiol:norethindrone acetate (20:1000 mu g daily over 22 months). A total Of 88 altered or atypical conditions of the vaginal surface appearance were recorded in 507 inspections (17.4% of inspections). Many of these atypical appearances were quite subtle. The incidence was significantly higher (p < 0.01) than in the single pretreatment examinations (11 in 158 inspections; 7.0%), but closely matched that of a "control group" of sexually active women who were the subject of an earlier study by the same investigators. In that study, the incidence was 18% (57 atypical conditions in 327 inspections). In all, 83% of atypical conditions identified in the vagina during ring use had disappeared by the next scheduled colposcopy despite continued ring use. Findings of potential significance were conservatively defined as all ulcerations, those abrasions and ecchymoses that were >0.5 cm in any direction, and fields of five or more petechiae. Findings fitting those criteria comprised 30% of atypical conditions in ring users, 33% in the control group, and 27% pretreatment. The corresponding incidence as a percentage of inspections were 5.3%, 6.0%, and 2.5% in the ring users, control groups, and pretreatment groups, respectively. These differences were not statistically significant. The findings suggest that the vaginal rings included in the studies contributed little, if at all, so clinically significant lesions or to total lesion incidence. Further definition would require a larger and longer-term study with matched controls. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 15 条
[1]  
BALOGH SA, 1994, CONTRACEPTION, V50, P517
[2]   PRELIMINARY-REPORT OF UNEXPECTED LOCAL REACTIONS TO A PROGESTOGEN-RELEASING CONTRACEPTIVE VAGINAL RING [J].
BOUNDS, W ;
SZAREWSKI, A ;
LOWE, D ;
GUILLEBAUD, J .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 48 (02) :123-125
[3]  
BURGOS MH, 1986, HUMAN VAGINA, P63
[4]   Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women [J].
Fraser, IS ;
Lähteenmaki, P ;
Elomaa, K ;
Lacarra, M ;
Mishell, DR ;
Alvarez, F ;
Brache, V ;
Weisberg, E ;
Hickey, M ;
Vallentine, P ;
Nash, HA .
HUMAN REPRODUCTION, 1999, 14 (08) :1974-1978
[5]  
LANGREN BM, 1987, FERTILITY REGULATION, P165
[6]   AN UNUSUAL VAGINAL FOREIGN-BODY [J].
NICHOLLS, J .
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1993, 33 (01) :101-102
[7]   CONTRACEPTION WITH A VAGINAL RING RELEASING 3-KETO DESOGESTREL AND ETHINYLESTRADIOL [J].
OLSSON, SE ;
ODLIND, V .
CONTRACEPTION, 1990, 42 (05) :563-572
[8]   A DOSING STUDY OF NONOXYNOL-9 AND GENITAL IRRITATION [J].
RODDY, RE ;
CORDERO, M ;
CORDERO, C ;
FORTNEY, JA .
INTERNATIONAL JOURNAL OF STD & AIDS, 1993, 4 (03) :165-170
[9]   MICRODOSE INTRAVAGINAL LEVONORGESTREL CONTRACEPTION - A MULTICENTER CLINICAL-TRIAL .1. CONTRACEPTIVE EFFICACY AND SIDE-EFFECTS [J].
ROWE, PJ .
CONTRACEPTION, 1990, 41 (02) :105-124
[10]  
SHOUPE D, 1992, CONTRACEPTION NEWER, P71